BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 27395059)

  • 1. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
    Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
    Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Chandler H; Brooks DJ; Hattersley G; Bouxsein ML; Lanske B
    Osteoporos Int; 2019 Aug; 30(8):1607-1616. PubMed ID: 31053927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.
    Varela A; Chouinard L; Lesage E; Guldberg R; Smith SY; Kostenuik PJ; Hattersley G
    Bone; 2017 Feb; 95():143-150. PubMed ID: 27894941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
    Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
    J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis.
    Besschetnova T; Brooks DJ; Hu D; Nagano K; Nustad J; Ominsky M; Mitlak B; Hattersley G; Bouxsein ML; Baron R; Lanske B
    Bone; 2019 Jul; 124():148-157. PubMed ID: 31051317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M; Zeng GQ; Turner CH
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin suppresses intervertebral disk degeneration and preserves lumbar vertebral bone mineral density and bone strength in ovariectomized rats.
    Tian FM; Yang K; Wang WY; Luo Y; Li SY; Song HP; Zhang YZ; Shen Y; Zhang L
    Osteoporos Int; 2015 Dec; 26(12):2853-61. PubMed ID: 26104796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
    Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption.
    Chandler H; Lanske B; Varela A; Guillot M; Boyer M; Brown J; Pierce A; Ominsky M; Mitlak B; Baron R; Kostenuik P; Hattersley G
    Bone; 2019 Mar; 120():148-155. PubMed ID: 30343166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
    Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
    Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner.
    Mosekilde L; Thomsen JS; Orhii PB; Kalu DN
    Bone; 1998 Oct; 23(4):343-52. PubMed ID: 9763146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats.
    Thomsen JS; Mosekilde LI; Gasser JA
    Bone; 1999 Nov; 25(5):561-9. PubMed ID: 10574576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Okubo R; Sanada LS; Castania VA; Louzada MJ; de Paula FJ; Maffulli N; Shimano AC
    Osteoporos Int; 2017 Apr; 28(4):1461-1471. PubMed ID: 28124728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.